NDC 71432-2002-01 - tacrolimus
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71432-2002
- Requested NDC
- 71432-2002-01
- Package NDCs from labels
- 71432-2002-1, 71432-2002-01
- Manufacturer
- Chengdu Suncadia Medicine Co., Ltd.
- Effective date
- 2024-02-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| tacrolimus extended-release capsules - Chengdu Suncadia Medicine Co., Ltd. | Chengdu Suncadia Medicine Co., Ltd. | 2024-02-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71432-2002-1 | tacrolimus | 5 in 1 BAG | CAPSULE, COATED, EXTENDED RELEAS | 5 | 5 | |
| 71432-2002-1 | tacrolimus | 1 in 1 CARTON | CAPSULE, COATED, EXTENDED RELEAS | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71432-2002 | TACROLIMUS (TACROLIMUS EXTENDED-RELEASE CAPSULES) CAPSULE, COATED, EXTENDED RELEASE [CHENGDU SUNCADIA MEDICINE CO., LTD.] | 5 | Current NDC, 2 package rows | 20240213_08cf2861-2483-405d-a872-a88a5c235f9a.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tacrolimus | TACROLIMUS | Stellon Biotech Inc. | 6b89e8a4-9f11-42e3-8e79-fe617e7c461f | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | Major Pharmaceuticals | 213f6047-f897-48a7-b78a-45d7124f2f16 | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| tacrolimus | TACROLIMUS | A-S Medication Solutions | 3519febc-c9df-4559-b07a-92f8b0c7e770 | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| tacrolimus | TACROLIMUS | NORTHSTAR RX LLC | 875f4962-557e-4e12-ad7b-cb5fb6f2a65f | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | Major Pharmaceuticals | 0addf3f5-9bd5-4ef3-8c7f-52be20c16cf9 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | Glenmark Pharmaceuticals Inc., USA | c2d2e3a1-f346-4245-b445-6dd44e371180 | 2026-04-15 | Warnings, Adverse reactions | WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | Safecor Health LLC | 393cd10e-133c-4d6b-b024-270eb82edbb3 | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | Jubilant Cadista Pharmaceuticals Inc. | 651bd506-96b0-43e5-a4dd-db03bf9154c9 | 2026-03-16 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 1bf44a84-14fd-4f80-ad8a-99b1431d631f | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| tacrolimus | TACROLIMUS | Glenmark Pharmaceuticals Inc., USA | 4b310c6b-e035-4e44-9573-4001d58b2ad5 | 2026-01-21 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| ASTAGRAF XL | TACROLIMUS EXTENDED-RELEASE CAPSULES | Astellas Pharma US, Inc. | 550a5cd4-fbf2-4c09-b577-6bde8fcbdf6e | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | 1431980 1431985 1431971 WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | BPI Labs LLC | 3e8bc65e-8048-4073-8e45-570330603000 | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | Ajenat Pharmaceuticals LLC | ca08d4aa-3de2-4a9d-9554-6288e5d36f29 | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | Ascend Laboratories, LLC | 55467f4b-8437-43a3-b6d9-1bc2a13b4c11 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | Golden State Medical Supply, Inc. | 34ec4989-6933-4237-ae1e-50a0cb90a2fe | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | Cardinal Health 107, LLC | e898ee90-faae-42a8-b652-be1c8730d856 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | Nexus Pharmaceuticals, LLC | 9d502961-e9c0-4611-92bf-ce742a7b962c | 2025-12-02 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | Amneal Pharmaceuticals NY LLC | 4eb1b6bd-beec-4dd5-9a48-c93a9fe918b3 | 2025-10-20 | Boxed warning, Warnings, Adverse reactions | ANDA215012 1431980 1431985 1431971 WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS OINTMENT 0.1% | Encube Ethicals, Inc. | 43b38551-6c5e-48a4-a453-9286f1c16b34 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
| Tacrolimus | TACROLIMUS | Bryant Ranch Prepack | a2e55495-10cc-4f6e-b866-1e7d6e45888b | 2025-08-25 | Boxed warning, Warnings, Adverse reactions | WM0HAQ4WNM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.